Cardiologists recently completed their first transcatheter tricuspid valve replacement (TTVR) procedure, becoming the first hospital in the Sacramento region to perform the minimally invasive treatment.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
